Seasonal trivalent influenza vaccine (TIV)

Influenza vaccine, seasonal, trivalent · Sanofi Pasteur

Drug timelines are a Plus or Pro feature.

2 regulatory and trial events tracked for Seasonal trivalent influenza vaccine (TIV), covering 2011-05-10 to 2016-02-23. Get the full timeline:

Most recent: Clinical Trial Update: Phase II Study to Assess Safety & Immunogenicity of Multimeric-001 Influenza Vaccine, Followed by TIV [Phase 2]